Clarivate (CLVT)

Executive Summary

Clarivate is a UK-based global leader in transformative intelligence, offering enriched data, analytics, workflow solutions, and expert services to the Academia & Government, Life Sciences & Healthcare, and Intellectual Property sectors. Founded in 2016 and publicly traded (NYSE: CLVT), the company combines AI and human expertise to accelerate innovation and support critical decision-making for organizations worldwide. With a valuation of ~$1.57 billion and ongoing investments in AI-enabled platforms, Clarivate is positioned to benefit from secular trends in R&D digitization and IP management. However, the company faces headwinds from macroeconomic uncertainty and intense competition from specialized analytics providers. Its diverse customer base and recurring revenue streams provide stability, while recent product enhancements and strategic acquisitions aim to drive growth. The conviction score reflects a balanced view of its market leadership and execution risks.

Upcoming Catalysts (preview)

• Q2 2026Launch of next-gen AI-driven analytics platform for life sciences80% success
• May 2026Q1 2026 earnings beat and raised guidance60% success
• Q3 2026Potential strategic acquisition in the IP analytics space45% success